Elevance Health Inc (NYSE: ELV) is -46.93% lower on its value in year-to-date trading and has touched a low of $276.41 and a high of $567.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELV stock was last observed hovering at around $277.09 in the last trading session, with the day’s loss setting it -0.64%.
Currently trading at $276.45, the stock is -20.63% and -25.59% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.58 million and changing -0.23% at the moment leaves the stock -31.32% off its SMA200. ELV registered -25.06% loss for a year compared to 6-month loss of -28.24%. The firm has a 50-day simple moving average (SMA 50) of $374.3362 and a 200-day simple moving average (SMA200) of $403.744.
The stock witnessed a -26.46% gain in the last 1 month and extending the period to 3 months gives it a -34.88%, and is -18.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.33% over the week and 3.17% over the month.
Elevance Health Inc (ELV) has around 104200 employees, a market worth around $62.25B and $189.25B in sales. Current P/E ratio is 11.77 and Fwd P/E is 8.31. Profit margin for the company is 2.83%. Distance from 52-week low is 0.01% and -51.27% from its 52-week high. The company has generated returns on investments over the last 12 months (7.45%).
The EPS is expected to shrink by -6.59% this year.
Elevance Health Inc (ELV) Top Institutional Holders
2230.0 institutions hold shares in Elevance Health Inc (ELV), with institutional investors hold 93.23% of the company’s shares. The shares outstanding are 224.84M, and float is at 224.79M with Short Float at 1.13%. Institutions hold 93.07% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 21.21 million shares valued at $11.49 billion. The investor’s holdings represent 9.133% of the ELV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 20.7 million shares valued at $11.22 billion to account for 8.9168 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 11.65 million shares representing 5.0157% and valued at over $6.31 billion, while STATE STREET CORP holds 4.5471 of the shares totaling 10.56 million with a market value of $5.72 billion.
Elevance Health Inc (ELV) Insider Activity
The most recent transaction is an insider purchase by BOUDREAUX GAIL,the company’sPresident and CEO. SEC filings show that BOUDREAUX GAIL bought 8,500 shares of the company’s common stock on Jul 18 ’25 at a price of $286.94 per share for a total of $2.44 million. Following the purchase, the insider now owns 0.15 million shares.
Elevance Health Inc disclosed in a document filed with the SEC on Apr 24 ’25 that Kaye Mark (EVP & CFO) sold a total of 4,588 shares of the company’s common stock. The trade occurred on Apr 24 ’25 and was made at $424.82 per share for $1.95 million. Following the transaction, the insider now directly holds 18977.0 shares of the ELV stock.
